346
Views
2
CrossRef citations to date
0
Altmetric
REVIEW

A Systematic Review of the Hill-Bone Compliance to Blood Pressure Therapy Scale

, , , , , , , , & ORCID Icon show all
Pages 2401-2420 | Received 12 Mar 2023, Accepted 05 Aug 2023, Published online: 28 Sep 2023

References

  • Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics—2023 update: a report from the American heart association. Circulation. 2023;147(8):e93–e621. doi:10.1161/CIR.0000000000001123
  • Carey RM, Aronow WS, Casey DE, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Nnals Inter Med. 2018;168:1524–4563.
  • Follow up Program Cooperative Grou. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension detection and follow-up program cooperative group. JAMA. 1979;242:0098–7484.
  • SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:0098–7484.
  • Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypert. 2008;10:1524–6175.
  • Osterberg L, Blaschke T. Adherence to medication. New Engl J Med. 2005;353:1533–4406.
  • van der Laan DM, Elders PJM, Boons C, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Human Hypert. 2017;31:1476–5527.
  • Ogungbe O, Himmelfarb CR, Commodore-Mensah Y. Improving medication adherence in cardiovascular disease prevention: what’s new? J Cardiovasc Nurs. 2020;2020:1550–5049.
  • Ogungbe O, Byiringiro S, Adedokun-Afolayan A, et al. Medication adherence interventions for cardiovascular disease in low- and middle-income countries: a systematic review. Patient Prefer Adher. 2021;2021:1177–889X.
  • Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. JAMA. 2013;309(20):2105–2106. doi:10.1001/jama.2013.4638
  • MacLaughlin EJ, Raehl Cl Fau - Treadway AK, Treadway Ak Fau - Sterling TL, Sterling Tl Fau - Zoller DP, Zoller Dp Fau - Bond CA, Bond CA. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22:1170–229X.
  • Wagner JH, Justice Ac Fau - Chesney M, Chesney M, et al. Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. J Clinl Epidemiol. 2001;54:0895–4356.
  • Kelly MS, Moczygemba LR, Gatewood SS. Concordance of pharmacist assessment of medication nonadherence with a self-report medication adherence scale. J Pharm Pract. 2016;29:1531–1937.
  • Nguyen TM, La Caze A, Fau - Cottrell N, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77:1365–2125.
  • Kim MT, Levine DM. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog Cardiov Nurs. 2000;2000:0889–7204.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
  • Veritas health innovation; Available from: www.covidence.org. Accessed September 01, 2023.
  • Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Anna Inter Med. 2011;155:1539–3704.
  • Abel WM, Crane PB, McCoy T. Predictors of depression in black women with hypertension. Issu Ment Health Nurs. 2014;35:1096–4673.
  • Al-daken LI, Eshah NF. Self-reported adherence to therapeutic regimens among patients with hypertension. Clin Exp Hypertens. 2017;39(3):264–270. doi:10.1080/10641963.2016.1247164
  • Alsolami F, Hou X-Y, Correa-Velez I. An Arabic instrument to measure medication adherence in Saudi hypertensive patients. Middle East J Fam Med. 2013;11:17–23. doi:10.5742/MEFM.2014.92409
  • Asadullah IS, Ali H, Ul Haq N, Zarak MS, Nasim A. Assessment of medication adherence among hypertensive patients by using hill-bone compliance scale in tertiary care hospitals quetta. Indo Am J Pharm Sci. 2018;5(5):3796–3803. doi:10.5281/zenodo.1248144
  • Boulware LE, Carson KA, Troll MU, Powe NR, Cooper LA. Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices. J Gen Intern Med. 2009;24(10):1123–1129. doi:10.1007/s11606-009-1086-6
  • Chatziefstratiou A, Giakoumidakis K, Fotos NV, Baltopoulos G, Brokalaki H. Scales for assessing medication adherence in patients with hypertension. Br J Nurs. 2019;28(21):1388–1392. doi:10.12968/bjon.2019.28.21.1388
  • Cheong AT, Tong SF, Sazlina SG. Validity and reliability of the Malay version of the hill-bone compliance to high blood pressure therapy scale for use in primary healthcare settings in Malaysia: a cross-sectional study. Malays Fam Physician. 2015;10(2):36–44.
  • Chudiak A, Jankowska-Polańska B, Uchmanowicz I. Effect of frailty syndrome on treatment compliance in older hypertensive patients. Clin Interv Aging. 2017;12:805–814. doi:10.2147/CIA.S126526
  • Chudiak A, Uchmanowicz I, Mazur G. Relation between cognitive impairment and treatment adherence in elderly hypertensive patients. Clin Interv Aging. 2018;13:1409–1418. doi:10.2147/CIA.S162701
  • Dennison CR, Peer N, Steyn K, Levitt NS, Hill MN. Determinants of hypertension care and control among peri-urban Black South Africans: the HIHI study. Ethn Dis. 2007;17(3):484–491.
  • Dharan DR, Moly KT. Factors influencing compliance to therapeutic regimen among patients with hypertension. Asian J Pharm Clin Res. 2017;10(12):286–289. doi:10.22159/ajpcr.2017.v10i12.21034
  • Etebari F, Pezeshki MZ, Fakour S. Factors related to the non-adherence of medication and nonpharmacological recommendations in high blood pressure patients. J Cardiovasc Thorac Res. 2019;11(1):28–34. doi:10.15171/jcvtr.2019.05
  • Fleig SV, Weger B, Haller H, Limbourg FP. Effectiveness of a fixed-dose, single-pill combination of perindopril and amlodipine in patients with hypertension: a non-interventional study. Adv Ther. 2018;35(3):353–366. doi:10.1007/s12325-018-0675-3
  • Fongwa MN, Nandy K, Qing Y, Hays RD. The facilitators of and barriers to adherence to hypertension treatment scale. J Cardiovasc Nurs. 2015;30(6):484–490. doi:10.1097/JCN.0000000000000206
  • Gerber BS, Cho YI, Arozullah AM, et al. Racial differences in medication adherence: a cross-sectional study of Medicare enrollees. Am J Geriat Pharmacoth. 2010;8:1876–7761.
  • Glasgow RE, Kurz D, King D, et al. Twelve-month outcomes of an internet-based diabetes self-management support program. Patient Educ Couns. 2012;87(1):81–92. doi:10.1016/j.pec.2011.07.024
  • Greer DB, Abel WM. Religious/Spiritual Coping in Older African American Women. Qual Rep. 2017;22(1):237–260.
  • Greer DB, Ostwald SK. Improving adherence in African American women with uncontrolled hypertension. J Cardiovas Nurs. 2015;30:1550–5049.
  • Han H-R, Lee H, Commodore-Mensah Y, Kim M. Development and validation of the hypertension self-care profile: a practical tool to measure hypertension self-care. J Cardiovasc Nurs. 2014;29(3):E11–E20. doi:10.1097/JCN.0b013e3182a3fd46
  • Hill-Briggs F, Gary TL, Yeh HC, et al. Association of social problem solving with glycemic control in a sample of urban African Americans with type 2 diabetes. J Behav Med. 2006;29:0160–7715.
  • Hsu Y-H, Mao C-L, Wey M. Antihypertensive medication adherence among elderly Chinese Americans. J Transcult Nurs. 2010;21(4):297–305. doi:10.1177/1043659609360707
  • Ingram RR, Ivanov LL. Examining the association of health literacy and health behaviors in African American older adults: does health literacy affect adherence to antihypertensive regimens? J Gerontol Nurs. 2013;39(3):22–32; quiz 33. doi:10.3928/00989134-20130201-01
  • Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the HillBone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15(4):207–211. doi:10.3109/13814780903452150
  • Kim E-Y, Han H-R, Jeong S, et al. Does knowledge matter? Intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs. 2007;22(5):397–404. doi:10.1097/01.JCN.0000287038.23186.bd
  • Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63(3):299–306. doi:10.1016/j.jclinepi.2009.06.011
  • Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005;330(3):128–133. doi:10.1097/00000441-200509000-00006
  • Krousel-Wood MA, Islam T, Muntner P, et al. Medication adherence in older clinic patients with hypertension after Hurricane Katrina: implications for clinical practice and disaster management. Am J Med Sci. 2008;336(2):99–104. doi:10.1097/MAJ.0b013e318180f14f
  • Krousel-Wood M, Joyce C, Holt EW, et al. Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension. Pharmacotherapy. 2013;33(8):798–811. doi:10.1002/phar.1275
  • Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16(1):286–291.
  • Mafutha GN, Wright SC. Compliance or non-compliance of hypertensive adults to hypertension management at three primary healthcare day clinics in Tshwane. Curationis. 2013;36(1):E1–E6. doi:10.4102/curationis.v36i1.52
  • Manze MG, Orner MB, Glickman M, Pbert L, Berlowitz D, Kressin NR. Brief provider communication skills training fails to impact patient hypertension outcomes. Patient Educ Couns. 2015;98(2):191–198. doi:10.1016/j.pec.2014.10.014
  • Maslakpak MH, Rezaei B, Parizad N. Does family involvement in patient education improve hypertension management? A single-blind randomized, parallel group, controlled trial. Cogent Med. 2018;5(1):1537063. doi:10.1080/2331205X.2018.1537063
  • Mutneja E, Yadav R, Dey AB, Gupta P. Frequency and predictors of compliance among patients taking antihypertensive medicines. Indian Heart J. 2020;72:136–139. doi:10.1016/j.ihj.2020.03.008
  • Nashilongo MM, Singu B, Kalemeera F, et al. Assessing adherence to antihypertensive therapy in primary health care in Namibia: findings and implications. Cardiovasc Drugs Ther. 2017;31(5–6):565–578. doi:10.1007/s10557-017-6756-8
  • Ndumele CD, Shaykevich S, Williams D, Hicks LS. Disparities in adherence to hypertensive care in urban ambulatory settings. J Health Care Poor Underserved. 2010;21(1):132–143. doi:10.1353/hpu.0.0259
  • Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayles TM, Brant SR. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(8):1233–1239. doi:10.1002/ibd.20883
  • Nogueira-Silva L, Sá-Sousa A, Lima MJ, Monteiro A, Dennison-Himmelfarb C, Fonseca JA. Translation and cultural adaptation of the hill-bone compliance to high blood pressure therapy scale to Portuguese. Rev Port Cardiol. 2016;35(2):93–97. doi:10.1016/j.repc.2015.07.013
  • Rose LE, Sawyer AL, Everett A. Cardiovascular health literacy and treatment adherence in persons with serious mental illness. Issues Ment Health Nurs. 2014;35(2):88–99. doi:10.3109/01612840.2013.843622
  • Sarfo FS, Mobula LM, Burnham G, et al. Factors associated with uncontrolled blood pressure among Ghanaians: evidence from a multicenter hospital-based study. PLoS One. 2018;13(3):e0193494. doi:10.1371/journal.pone.0193494
  • Shawler C, Edward J, Ling J, Crawford TN, Rayens MK. Impact of mother-daughter relationship on hypertension self-management and quality of life: testing dyadic dynamics using the actor-partner interdependence model. J Cardiovasc Nurs. 2018;33(3):232–238. doi:10.1097/JCN.0000000000000448
  • Song Y, Han HR, Song HJ, Nam S, Nguyen T, Kim MT. Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs Res. 2011;5(3):183–188. doi:10.1016/j.anr.2011.09.007
  • Uchmanowicz I, Jankowska-Polańska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the polish adaptation of the hill-bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16(1). doi:10.1186/s12872-016-0270-y
  • Uchmanowicz B, Chudiak A, Mazur G. The influence of quality of life on the level of adherence to therapeutic recommendations among elderly hypertensive patients. Patient Prefer Adherence. 2018;12:2593–2603. doi:10.2147/ppa.S182172
  • Uchmanowicz B, Chudiak A, Uchmanowicz I, Rosińczuk J, Froelicher ES. Factors influencing adherence to treatment in older adults with hypertension. Clin Interv Aging. 2018;13:2425–2441. doi:10.2147/CIA.S182881
  • Uchmanowicz B, Chudiak A, Uchmanowicz I, Mazur G. How may coexisting frailty influence adherence to treatment in elderly hypertensive patients? Int J Hypertens. 2019;2019:1–8. doi:10.1155/2019/5245184
  • Wang X, Robinson KM, Hardin HK. The impact of caregiving on caregivers’ medication adherence and appointment keeping. West J Nurs Res. 2015;37(12):1548–1562. doi:10.1177/0193945914533158
  • Zabihi RE, Ashktorab T, Banaderakhshan H, Zaeri F. Adherence to therapeutic regimens in patients with hypertension. ARYA Atheroscler. 2012;8:S190–S194.
  • Zare S, Rezaee R, Aslani A, Shirdeli M, Kojuri J. Moving toward community based telehealth services using mhealth for hypertensive patients. Int J Technol Assess Health Care. 2019;35(5):379–383. doi:10.1017/S0266462319000655
  • Zwar N, Hermiz O, Halcomb E, Davidson PM, Bodenheimer T. Improving blood pressure control in general practice: a pilot study of the ImPress intervention. Aust Fam Physician. 2017;46(5):306–311.
  • Culig J, Leppée M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Colleg Antropolog. 2014;38:0350–6134.
  • Gehi AK, Ali S, Fau - Na B, Na B, Fau - Whooley MA, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Inter Med. 2007;167:0003–9926.
  • Hamdidouche I, Jullien V, Laurent S, Azizi M. Detecting nonadherence to antihypertensive treatment. Hypertension. 2017;70(2):257–258. doi:10.1161/HYPERTENSIONAHA.117.09739
  • Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiov Dis. 2013;55:1873.
  • The hill-bone scales: hypertension and medication adherence scales. Available from: https://nursing.jhu.edu/faculty_research/research/projects/hill-bone/hill-bone-scales.html. Accessed September 01, 2023.
  • Gabriel A, Zare H, Jones W, et al. Evaluating depressive symptoms among low-socioeconomic-status African American women aged 40 to 75 years with uncontrolled hypertension: a secondary analysis of a randomized clinical trial. JAMA psychiatry. 2021;78:2168–6238.
  • Kim EY, Han HR, Jeong S, et al. Does knowledge matter?: intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovas Nurs. 2007;22:1550–5049.
  • Zhang J, Gong Y, Zhao Y, Jiang N, Wang J, Yin XA-O. Post-stroke medication adherence and persistence rates: a meta-analysis of observational studies. J Neurol. 2021;268:1432–1459.
  • Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adher. 2016;2016:1177–889X.
  • Smith D, Lovell J, Weller C, et al. A systematic review of medication non-adherence in persons with dementia or cognitive impairment. PLoS One. 2017;12:1932–6203.
  • Jackson CA, Clatworthy J, Fau - Robinson A, Robinson A, Fau - Horne R, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Official J Am Coll Gastroenterol. 2010;105:1572.
  • Mechta Nielsen T, Frøjk Juhl M, Feldt-Rasmussen B, Thomsen T. Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research. Clin Kidney J. 2018;11:2048–8505.
  • Stewart BJ, Archbold PG. Focus on psychometrics nursing intervention studies require outcome measures that are sensitive to change: part one. Res Nurs Health. 1992;15(6):477–481. doi:10.1002/nur.4770150610
  • Stewart BJ, Archbold PG. Nursing intervention studies require outcome measures that are sensitive to change: part two. Res Nurs Health. 1993;16(1):77–81. doi:10.1002/nur.4770160110
  • Morisky DE, Ang A, Krousel‐Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hyperten. 2008;10:1524–6175.
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care. 1986;1986:0025–7079.
  • Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. JClin Epidemiol. 2003;56(6):520.
  • Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings. Tzu-Chi Medical J. 2019;31:1016–3190.
  • Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383(2):120–128. doi:10.1056/NEJMoa2015432